First Time Loading...

Coca-Cola Europacific Partners PLC
NASDAQ:CCEP

Watchlist Manager
Coca-Cola Europacific Partners PLC Logo
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
Watchlist
Price: 71.81 USD 0.39% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

29.3B
-2%
Assets
Growth Rates:
1 Year
0%
3 Years
+52%
5 Years
+61%
7 Years
+58%
10 Years
+322%
21.3B
-3%
Liabilities
Growth Rates:
1 Year
-3%
3 Years
+61%
5 Years
+83%
7 Years
+76%
10 Years
+304%
8B
+3%
Equity
Growth Rates:
1 Year
+7%
3 Years
+32%
5 Years
+22%
7 Years
+23%
10 Years
+381%

Balance Sheet Decomposition
Coca-Cola Europacific Partners PLC

29.3B
Assets
21.3B
Liabilities
29.3B
Assets
21.3B
Liabilities
Current Assets 6.6B
Cash & Short-Term Investments 2B
Receivables 2.7B
Other Current Assets 1.9B
Non-Current Assets 22.6B
PP&E 5.3B
Intangibles 16.9B
Other Non-Current Assets 396m
Current Liabilities 7.3B
Accounts Payable 5.2B
Accrued Liabilities 8m
Other Current Liabilities 2B
Non-Current Liabilities 14B
Long-Term Debt 10.1B
Other Non-Current Liabilities 3.9B

Balance Sheet
Coca-Cola Europacific Partners PLC

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
152
78
279
304
279
170
643
708
491
465
Cash
152
78
279
304
279
170
643
708
491
465
Short-Term Investments
32
78
107
56
30
146
880
757
1 152
1 522
Total Receivables
1 330
1 275
2 270
2 229
1 914
1 969
1 608
2 494
2 690
2 728
Accounts Receivables
1 252
1 210
1 860
1 732
1 655
1 669
1 439
2 305
2 466
2 547
Other Receivables
78
65
410
497
259
300
169
189
224
181
Inventory
374
371
673
650
693
723
681
1 157
1 380
1 356
Other Current Assets
120
81
96
75
75
95
264
644
830
534
Total Current Assets
2 008
1 883
3 425
3 314
2 991
3 103
4 076
5 760
6 543
6 605
PP&E Net
1 673
1 692
3 993
3 837
3 888
4 205
3 860
5 248
5 201
5 344
PP&E Gross
1 673
1 692
3 993
3 837
3 888
4 205
3 860
5 248
5 201
5 344
Accumulated Depreciation
1 719
1 782
1 793
2 034
2 315
2 685
2 985
3 112
3 562
3 879
Intangible Assets
3 086
3 202
8 344
8 384
8 384
8 506
8 414
12 639
12 505
12 395
Goodwill
84
81
2 427
2 520
2 518
2 520
2 517
4 623
4 600
4 514
Other Long-Term Assets
197
138
379
139
435
351
370
820
464
396
Other Assets
84
81
2 427
2 520
2 518
2 520
2 517
4 623
4 600
4 514
Total Assets
7 048
N/A
6 996
-1%
18 568
+165%
18 194
-2%
18 216
+0%
18 685
+3%
19 237
+3%
29 090
+51%
29 313
+1%
29 254
0%
Liabilities
Accounts Payable
444
448
904
1 057
1 105
1 138
1 124
1 691
2 191
2 306
Accrued Liabilities
791
713
1 207
1 184
1 323
1 226
1 251
1 916
2 144
2 218
Short-Term Debt
121
183
0
250
120
221
0
285
0
0
Current Portion of Long-Term Debt
402
235
875
24
371
578
805
1 065
1 336
1 300
Other Current Liabilities
397
427
766
772
873
952
960
1 136
1 642
1 454
Total Current Liabilities
2 155
2 006
3 752
3 287
3 792
4 115
4 140
6 093
7 313
7 278
Long-Term Debt
2 731
3 122
5 562
5 474
5 127
5 622
6 382
11 790
10 571
10 096
Deferred Income Tax
790
769
2 248
2 237
2 157
2 203
2 134
3 617
3 513
3 378
Minority Interest
0
0
0
0
0
0
0
177
0
0
Other Liabilities
185
228
545
511
576
589
556
380
469
526
Total Liabilities
5 861
N/A
6 125
+5%
12 107
+98%
11 509
-5%
11 652
+1%
12 529
+8%
13 212
+5%
22 057
+67%
21 866
-1%
21 278
-3%
Equity
Common Stock
3
3
5
5
5
5
5
5
5
5
Retained Earnings
1 348
1 626
6 761
7 056
6 959
6 422
6 365
6 969
7 635
8 441
Additional Paid In Capital
2 711
2 729
114
127
152
178
192
220
234
276
Treasury Stock
2 781
3 307
0
0
0
0
0
0
0
0
Other Equity
94
180
419
503
552
449
537
161
427
746
Total Equity
1 187
N/A
871
-27%
6 461
+642%
6 685
+3%
6 564
-2%
6 156
-6%
6 025
-2%
7 033
+17%
7 447
+6%
7 976
+7%
Total Liabilities & Equity
7 048
N/A
6 996
-1%
18 568
+165%
18 194
-2%
18 216
+0%
18 685
+3%
19 237
+3%
29 090
+51%
29 313
+1%
29 254
0%
Shares Outstanding
Common Shares Outstanding
239
227
483
485
475
456
457
456
457
459

See Also

Summary
CCEP intrinsic value, competitors valuation, and company profile.
DCF Valuation
CCEP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CCEP stock valuation using valuation multiples.
Wall Street Estimates
CCEP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CCEP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.